SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-124364
Filing Date
2020-04-29
Accepted
2020-04-29 07:00:57
Documents
4
Period of Report
2020-06-18
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d886947ddef14a.htm DEF 14A 337697
2 GRAPHIC g886947g03o75.jpg GRAPHIC 3822
3 GRAPHIC g886947pc1.jpg GRAPHIC 266207
4 GRAPHIC g886947pc2.jpg GRAPHIC 176501
  Complete submission text file 0001193125-20-124364.txt   954199
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 20827305
SIC: 2834 Pharmaceutical Preparations